Robotic-assisted Partial Nephrectomy for "Very Small" (<2 cm) Renal Mass: Results of a Multicenter Contemporary Cohort
- PMID: 33153954
- DOI: 10.1016/j.euf.2020.10.001
Robotic-assisted Partial Nephrectomy for "Very Small" (<2 cm) Renal Mass: Results of a Multicenter Contemporary Cohort
Abstract
Background: Patient with "very small" (<2 cm) renal mass can be offered active surveillance, thermal ablation, or partial nephrectomy. The management strategy will consider patient preferences and prioritize potential harms associated with each of these options. To date, outcomes of robot-assisted partial nephrectomy (RAPN) in patients with "very small" renal masses have not been reported.
Objective: To assess the outcomes of RAPN among patients with "very small" renal masses.
Design, setting, and participants: This was a retrospective analysis of a multi-institutional database including RAPN cases performed at eight high-volume US and European centers between 2009 and 2019. Patients were stratified into two groups according to clinical tumor size: <2 cm ("very small" renal mass, study group) and 2-4 cm (control group).
Intervention: RAPN for renal masses.
Outcome measurements and statistical analysis: Baseline characteristics and intraoperative, pathological, and postoperative data were compared between the study and the control group. A "trifecta" was used as surrogate of "surgical quality."
Results and limitations: Overall, a total of 1019 patients were included in the analysis. Of these, 352 had a renal mass of <2 cm (34.5%) and 667 (65.5%) had a renal mass of 2-4 cm. At baseline, the study group presented a lower rate of chronic kidney disease ≥stage III (p < 0.001), a lower RENAL score (p = 0.001), and lower rates of hilar (p = 0.04) and endophytic (p = 0.02) masses. Warm ischemia time was shorter for the study group (median 14 vs 18 min, p < 0.001), which also showed a lower rate of overall postoperative complications (9.6% vs 14.7%, p < 0.001) and no major complications. In terms of oncological outcomes, three and ten patients developed a local recurrence in the study and the control group, respectively (p = 0.1). In the study group, higher estimated glomerular filtration rates were found at discharge (p = 0.001) and at the last follow-up (p = 0.007), which showed a "trifecta" achievement of 90.6%. The retrospective design may limit the generalizability of the findings.
Conclusions: Whenever an active treatment is indicated or warranted, RAPN represents a minimally invasive management option for "very small" renal masses, as it carries minimal risk of complications and has minimal impact on renal function. While both active surveillance and kidney ablation remain valid management options in these cases, RAPN can be offered and discussed with patients as it provides excellent outcomes with low morbidity.
Patient summary: In this report, we observed that robot-assisted partial nephrectomy represents a true minimally invasive active treatment for "very small" renal masses (<2 cm), as it carries minimal risk of complications and has minimal impact on renal function.
Keywords: Nephron-sparing surgery; Robotic partial nephrectomy; Small renal masses.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group).Eur Urol. 2018 Aug;74(2):226-232. doi: 10.1016/j.eururo.2018.05.004. Epub 2018 May 19. Eur Urol. 2018. PMID: 29784191
-
Percutaneous Ablation vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up.J Endourol. 2023 Mar;37(3):279-285. doi: 10.1089/end.2022.0478. Epub 2022 Nov 29. J Endourol. 2023. PMID: 36367175
-
Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.Eur Urol Oncol. 2019 Mar;2(2):207-213. doi: 10.1016/j.euo.2018.06.012. Epub 2018 Jul 14. Eur Urol Oncol. 2019. PMID: 31017098
-
Robot-assisted versus open partial nephrectomy: comparison of outcomes. A systematic review.Minerva Urol Nefrol. 2019 Apr;71(2):113-120. doi: 10.23736/S0393-2249.19.03391-5. Epub 2019 Mar 18. Minerva Urol Nefrol. 2019. PMID: 30895768
-
Intraoperative ultrasound in robot-assisted partial nephrectomy: State of the art.Arch Ital Urol Androl. 2018 Sep 30;90(3):195-198. doi: 10.4081/aiua.2018.3.195. Arch Ital Urol Androl. 2018. PMID: 30362686 Review.
Cited by
-
Retroperitoneal versus transepritoneal robot-assisted partial nephrectomy for postero-lateral renal masses: an international multicenter analysis.World J Urol. 2021 Nov;39(11):4175-4182. doi: 10.1007/s00345-021-03741-2. Epub 2021 May 29. World J Urol. 2021. PMID: 34050813
-
Management of small renal mass: unmet needs and quest for high quality evidence.Transl Androl Urol. 2024 Apr 30;13(4):643-646. doi: 10.21037/tau-23-651. Epub 2024 Apr 7. Transl Androl Urol. 2024. PMID: 38721283 Free PMC article. No abstract available.
-
Robot-Assisted Partial Nephrectomy Mid-Term Oncologic Outcomes: A Systematic Review.J Clin Med. 2022 Oct 19;11(20):6165. doi: 10.3390/jcm11206165. J Clin Med. 2022. PMID: 36294486 Free PMC article. Review.
-
Management of Small Renal Masses <2 cm: Treatment.Eur Urol Open Sci. 2025 Mar 25;74:73-74. doi: 10.1016/j.euros.2023.12.010. eCollection 2025 Apr. Eur Urol Open Sci. 2025. PMID: 40225288 Free PMC article. No abstract available.
-
Alkaline phosphatase combines with CT factors for differentiating small (≤ 4 cm) fat-poor angiomyolipoma from renal cell carcinoma: a multiple quantitative tool.World J Urol. 2023 May;41(5):1345-1351. doi: 10.1007/s00345-023-04367-2. Epub 2023 Apr 24. World J Urol. 2023. PMID: 37093317
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical